Document is current
Any future updates will be listed below
-
Authors
Lehrke, Michael
Fuernau, Georg https://orcid.org/0000-0002-3813-8772
Jung, Christian
Kahles, Florian
Moellmann, Julia
Eitel, Ingo
Thelemann, Nathalie
Desch, Steffen
Werdan, Karl
Zeymer, Uwe
Adams, Volker
Marx, Nikolaus
Thiele, Holger
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (174100157)
- License Information
-
More Information
Article History
Received: 3 September 2023
Accepted: 14 December 2023
First Online: 3 January 2024
Declarations
:
: ML received grants and personal fees from Boehringer Ingelheim, grants and personal fees from MSD, grants and personal fees from Novo Nordisk, personal fees from Amgen, personal fees from Sanofi, personal fees from Astra Zeneca, personal fees from Bayer, personal fees from Lilly. FK has served as a speaker for Novo Nordisk, JM declares no conflict of interest, NM has served as speaker for Amgen, Bayer, Boehringer Ingelheim, Sanofi-Aventis, MSD, BMS, AstraZeneca, Lilly, NovoNordisk. All other authors declare no conflict of interests.
